Key Insights from the 2025 ACC/AHA High Blood Pressure Guideline

Select Content Type
Briefs
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
ACC_thmbnl
Detail Image
ACC_mob det
Book Detail
Upload PDF
Key Insights from 2025 ACC AHA Guidelines (1).pdf (125.79 KB)
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

The 2025 ACC/AHA High Blood Pressure Guideline introduces significant changes to hypertension management, shifting towards a more personalized, risk-based approach to treatment. Replacing the 2017 guideline, the update incorporates the new PREVENT risk calculator, revised medication initiation thresholds, expanded screening recommendations, and a stronger emphasis on lifestyle interventions and health equity.

Published Date